Hickey returns to U.S. for new role at Pfizer
Plus Kaundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and more
Christopher Hickey, the China policy and public affairs lead at Pfizer Inc. (NYSE:PFE), is returning to Washington in the summer to transition into a new role. While remaining a member of the global policy team, Hickey’s new role at Pfizer will include supporting the key China-related events as well as other global policy and public affairs work, cutting across markets and business units. Hickey was previously the director of FDA’s China office.
Ganesh Kaundinya, who has been a board member at GlycoERA AG since its inception in 2020, is now the company’s president and CEO. Kaundinya was founder, COO and CSO of Momenta Pharmaceuticals Inc., which Johnson & Johnson (NYSE:JNJ) acquired in 2020. GlycoERA is developing glycoengineered therapeutics...